Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. reported earnings results for the nine months ended September 30, 2024. For the nine months, the company reported sales was CNY 820.39 million compared to CNY 653.79 million a year ago. Revenue was CNY 820.39 million compared to CNY 653.79 million a year ago.

Net income was CNY 182.59 million compared to CNY 141.34 million a year ago. Basic earnings per share from continuing operations was CNY 0.57 compared to CNY 0.4385 a year ago. Diluted earnings per share from continuing operations was CNY 0.57 compared to CNY 0.4385 a year ago.